Hooshmand Sheshbaradaran
Chief Operating Officer at BETTERLIFE PHARMA INC.
Net worth: 103 971 $ as of 30/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Glenn Walthall | M | - |
Bold Therapeutics, Inc.
Bold Therapeutics, Inc. BiotechnologyHealth Technology Bold Therapeutics, Inc. is a Canadian clinical-stage biopharmaceutical company that was founded in 2018 by a team of industry veterans to develop and commercialize novel therapeutics. The company is based in Vancouver, Canada. The company's focus is on developing Bold-100, a drug that has the potential to significantly improve outcomes in a wide range of both solid and liquid tumors in combination with other anticancer therapies. Edward Russell McAllister has been the CEO of the company since 2018.
Intezyne Technologies, Inc.
Intezyne Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Intezyne Technologies, Inc. develops therapeutic and diagnostic technologies. The firm is a clinical stage biotechnology company. The company was founded by Habib Skaff and Kevin N. Sill in 2004 and is headquartered in Tampa, FL. | 7 years |
Ahmad Doroudian | M | 63 | 4 years | |
Wolfgang Renz | M | 54 | 9 years | |
Edward Russell McAllister | M | - |
Intezyne Technologies, Inc.
Intezyne Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Intezyne Technologies, Inc. develops therapeutic and diagnostic technologies. The firm is a clinical stage biotechnology company. The company was founded by Habib Skaff and Kevin N. Sill in 2004 and is headquartered in Tampa, FL. | 6 years |
Robert Metcalfe | M | 84 | 4 years | |
Edward Russell McAllister | M | - |
Bold Therapeutics, Inc.
Bold Therapeutics, Inc. BiotechnologyHealth Technology Bold Therapeutics, Inc. is a Canadian clinical-stage biopharmaceutical company that was founded in 2018 by a team of industry veterans to develop and commercialize novel therapeutics. The company is based in Vancouver, Canada. The company's focus is on developing Bold-100, a drug that has the potential to significantly improve outcomes in a wide range of both solid and liquid tumors in combination with other anticancer therapies. Edward Russell McAllister has been the CEO of the company since 2018. | 6 years |
Moira Ong | F | 49 | 14 years | |
Ralph Pullen | M | 79 | 4 years | |
Jim Pankovich | M | - |
Bold Therapeutics, Inc.
Bold Therapeutics, Inc. BiotechnologyHealth Technology Bold Therapeutics, Inc. is a Canadian clinical-stage biopharmaceutical company that was founded in 2018 by a team of industry veterans to develop and commercialize novel therapeutics. The company is based in Vancouver, Canada. The company's focus is on developing Bold-100, a drug that has the potential to significantly improve outcomes in a wide range of both solid and liquid tumors in combination with other anticancer therapies. Edward Russell McAllister has been the CEO of the company since 2018. | - |
Carolyn M. Paradise | M | - |
Intezyne Technologies, Inc.
Intezyne Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Intezyne Technologies, Inc. develops therapeutic and diagnostic technologies. The firm is a clinical stage biotechnology company. The company was founded by Habib Skaff and Kevin N. Sill in 2004 and is headquartered in Tampa, FL. | 10 years |
Simon Sutcliffe | M | - |
Bold Therapeutics, Inc.
Bold Therapeutics, Inc. BiotechnologyHealth Technology Bold Therapeutics, Inc. is a Canadian clinical-stage biopharmaceutical company that was founded in 2018 by a team of industry veterans to develop and commercialize novel therapeutics. The company is based in Vancouver, Canada. The company's focus is on developing Bold-100, a drug that has the potential to significantly improve outcomes in a wide range of both solid and liquid tumors in combination with other anticancer therapies. Edward Russell McAllister has been the CEO of the company since 2018. | - |
David Melles | M | - | 3 years | |
Justin D. Kirkland | M | - | - | |
Michael Kulke | M | - |
Niiki Pharma, Inc.
Niiki Pharma, Inc. Pharmaceuticals: OtherHealth Technology Niiki Pharma, Inc. manufactures chemicals and botanical products. It specializes in cancer treatments directed at novel cellular targets and related companion diagnostics. The company was founded by Hooshmand Sheshbaradaran, Ardakana Ali and Jay Z. Zhang in 2007 and is headquartered in Hoboken, NJ. | - |
Anthony Calandra | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Habib Skaff | M | 47 |
Intezyne Technologies, Inc.
Intezyne Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Intezyne Technologies, Inc. develops therapeutic and diagnostic technologies. The firm is a clinical stage biotechnology company. The company was founded by Habib Skaff and Kevin N. Sill in 2004 and is headquartered in Tampa, FL. | 12 years |
Kevin N. Sill | M | - |
Intezyne Technologies, Inc.
Intezyne Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Intezyne Technologies, Inc. develops therapeutic and diagnostic technologies. The firm is a clinical stage biotechnology company. The company was founded by Habib Skaff and Kevin N. Sill in 2004 and is headquartered in Tampa, FL. | 14 years |
John McBride | M | 72 |
Intezyne Technologies, Inc.
Intezyne Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Intezyne Technologies, Inc. develops therapeutic and diagnostic technologies. The firm is a clinical stage biotechnology company. The company was founded by Habib Skaff and Kevin N. Sill in 2004 and is headquartered in Tampa, FL. | - |
Timothy D. Coan | M | - |
Intezyne Technologies, Inc.
Intezyne Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Intezyne Technologies, Inc. develops therapeutic and diagnostic technologies. The firm is a clinical stage biotechnology company. The company was founded by Habib Skaff and Kevin N. Sill in 2004 and is headquartered in Tampa, FL. | - |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 12 | 63.16% |
United States | 8 | 42.11% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hooshmand Sheshbaradaran
- Personal Network